Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Acid suppressive agents and risk of Mycobacterium tuberculosis: case-control study.

Hsu WH, Kuo CH, Wang SS, Lu CY, Liu CJ, Chuah SK, Kuo FC, Chen YH, Huang YB, Hou MF, Wu DC, Hu HM.

BMC Gastroenterol. 2014 May 13;14:91. doi: 10.1186/1471-230X-14-91.

2.

Underutilization of preventive strategies in patients receiving NSAIDs.

Sturkenboom MC, Burke TA, Dieleman JP, Tangelder MJ, Lee F, Goldstein JL.

Rheumatology (Oxford). 2003 Nov;42 Suppl 3:iii23-31.

PMID:
14585915
3.

Addition of a H2 receptor antagonist to PPI improves acid control and decreases nocturnal acid breakthrough.

Mainie I, Tutuian R, Castell DO.

J Clin Gastroenterol. 2008 Jul;42(6):676-9. doi: 10.1097/MCG.0b013e31814a4e5c.

PMID:
18496394
4.

Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs.

Laheij RJ, Sturkenboom MC, Hassing RJ, Dieleman J, Stricker BH, Jansen JB.

JAMA. 2004 Oct 27;292(16):1955-60.

PMID:
15507580
5.

The extent and determinants of prescribing and adherence with acid-reducing medications: a national claims database study.

El-Serag HB, Fitzgerald S, Richardson P.

Am J Gastroenterol. 2009 Sep;104(9):2161-7. doi: 10.1038/ajg.2009.312. Epub 2009 Jun 30.

PMID:
19568229
6.

Use of proton pump inhibitors and H2 blockers and risk of pneumonia in older adults: a population-based case-control study.

Dublin S, Walker RL, Jackson ML, Nelson JC, Weiss NS, Jackson LA.

Pharmacoepidemiol Drug Saf. 2010 Aug;19(8):792-802. doi: 10.1002/pds.1978.

7.

Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.

Leontiadis GI, Sreedharan A, Dorward S, Barton P, Delaney B, Howden CW, Orhewere M, Gisbert J, Sharma VK, Rostom A, Moayyedi P, Forman D.

Health Technol Assess. 2007 Dec;11(51):iii-iv, 1-164. Review.

8.

Association between traditional systemic antipsoriatic drugs and tuberculosis risk in patients with psoriasis with or without psoriatic arthritis: results of a nationwide cohort study from Taiwan.

Chen YJ, Wu CY, Shen JL, Chen TT, Chang YT.

J Am Acad Dermatol. 2013 Jul;69(1):25-33. doi: 10.1016/j.jaad.2012.12.966. Epub 2013 Jan 30.

PMID:
23375515
9.

Association between use of acid-suppressive drugs and risk of gastric cancer. A nested case-control study.

Tamim H, Duranceau A, Chen LQ, Lelorier J.

Drug Saf. 2008;31(8):675-84.

PMID:
18636786
10.

[Use of acid-suppressive medications in hospitalized patients].

Noguerado Asensio A, Rodríguez Barrientos R, Zelaya Castro P, Sánchez Sempere A, Antuña Blanco F, Lutz García E, Quintana de la Cruz R, Estellés Piera F, Alcázar MS.

An Med Interna. 2002 Nov;19(11):557-60. Spanish.

PMID:
12522890
11.

Impact of long-term gastric acid suppression on spontaneous bacterial peritonitis in patients with advanced decompensated liver cirrhosis.

Huang KW, Kuan YC, Luo JC, Lin CL, Liang JA, Kao CH.

Eur J Intern Med. 2016 Jul;32:91-5. doi: 10.1016/j.ejim.2016.04.016. Epub 2016 Apr 29.

PMID:
27139916
12.
13.

Proton-pump inhibitor use and the risk for community-acquired pneumonia.

Sarkar M, Hennessy S, Yang YX.

Ann Intern Med. 2008 Sep 16;149(6):391-8.

PMID:
18794558
14.

Effect of a proton pump inhibitor or an H2-receptor antagonist on prevention of bleeding from ulcer after endoscopic submucosal dissection of early gastric cancer: a prospective randomized controlled trial.

Uedo N, Takeuchi Y, Yamada T, Ishihara R, Ogiyama H, Yamamoto S, Kato M, Tatsumi K, Masuda E, Tamai C, Yamamoto S, Higashino K, Iishi H, Tatsuta M.

Am J Gastroenterol. 2007 Aug;102(8):1610-6. Epub 2007 Mar 31.

PMID:
17403076
15.
16.

Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection.

Howell MD, Novack V, Grgurich P, Soulliard D, Novack L, Pencina M, Talmor D.

Arch Intern Med. 2010 May 10;170(9):784-90. doi: 10.1001/archinternmed.2010.89.

PMID:
20458086
17.

Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease.

Dial S, Delaney JA, Barkun AN, Suissa S.

JAMA. 2005 Dec 21;294(23):2989-95.

PMID:
16414946
18.

Acid-suppressive medication use and the risk for hospital-acquired pneumonia.

Herzig SJ, Howell MD, Ngo LH, Marcantonio ER.

JAMA. 2009 May 27;301(20):2120-8. doi: 10.1001/jama.2009.722.

PMID:
19470989
19.

Differences in utilisation of gastroprotective drugs between 2001 and 2005 in Australia and Nova Scotia, Canada.

Tett SE, Sketris I, Cooke C, van Zanten SV, Barozzi N.

Pharmacoepidemiol Drug Saf. 2013 Jul;22(7):735-43. doi: 10.1002/pds.3442. Epub 2013 Apr 4.

PMID:
23559528
20.

Pharmacoepidemiology of stress ulcer prophylaxis in the United States and Canada.

Barletta JF, Kanji S, MacLaren R, Lat I, Erstad BL; American-Canadian consortium for Intensive care Drug utilization (ACID) Investigators.

J Crit Care. 2014 Dec;29(6):955-60. doi: 10.1016/j.jcrc.2014.06.025. Epub 2014 Jun 30.

PMID:
25081626

Supplemental Content

Support Center